PCVX - Vaxcyte Chief Operating Officer Acquires 3000 Shares After Exercising Company Stock Options | Benzinga
Jim Wassil, Chief Operating Officer at Vaxcyte (NASDAQ:PCVX), reported a large exercise of company stock options on September 26, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Wassil, Chief Operating Officer at Vaxcyte, a company in the Health Care sector, just exercised stock options worth 3,000 shares of PCVX stock with an exercise price of $2.42.
Vaxcyte shares are trading up 2.6% at $52.91 at the time of this writing on Wednesday morning. Since the current price is $52.91, this makes Wassil's 3,000 shares worth $158,730.
Now trade stocks online commission free with Charles Schwab, ...